secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2025-07-09T23:59:59+00:00
Accession:  0001641172-25-018393
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dare Bioscience shareholders approve 600,000-share increase to 2022 stock plan; re-elect directors
--------------------------------------------------------------------------------

- Stockholders re-elected directors Matz, Rastetter, and Steele; each received >2.4M votes for.
- Ratified Haskell & White LLP as independent auditor for FY2025 with 4.5M votes for, 106K against.
- Advisory say-on-pay resolution approved with 2.38M votes for, 243K against.
- Approved amendment increasing shares reserved under 2022 Stock Incentive Plan by 600,000 to 1,383,333.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000164117225018393/0001641172-25-018393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000164117225018393/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-018393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer